BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31614573)

  • 1. Differences in Expression of Human Leukocyte Antigen Class II Subtypes and T Cell Subsets in Behçet's Disease with Arthritis.
    Islam SMS; Kim HA; Choi B; Jung JY; Lee SM; Suh CH; Sohn S
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31614573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential activation of circulating CD8+ and gammadelta T cells in patients with active Behçet's disease and HLA-B51.
    Yasuoka H; Yamaguchi Y; Mizuki N; Nishida T; Kawakami Y; Kuwana M
    Clin Exp Rheumatol; 2008; 26(4 Suppl 50):S59-63. PubMed ID: 19026117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of human recombinant interferon-alpha2a (rhIFN-alpha2a) on altered lymphocyte subpopulations and monocytes in Behcet's disease.
    Treusch M; Vonthein R; Baur M; Günaydin I; Koch S; Stübiger N; Eckstein AK; Peter HH; Ness T; Zierhut M; Kötter I
    Rheumatology (Oxford); 2004 Oct; 43(10):1275-82. PubMed ID: 15252211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some specific human leukocyte antigen (HLA)-DR/DQ haplotypes are more important than individual HLA-DR and -DQ phenotypes for the development of mucocutaneous type of Behçet's disease and for disease shift from recurrent aphthous stomatitis to mucocutaneous type of Behçet's disease.
    Sun A; Hsieh RP; Chu CT; Wang JT; Liu BY; Chiang CP
    J Oral Pathol Med; 2001 Aug; 30(7):402-7. PubMed ID: 11488417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gammadelta T cells in Behçet's disease (BD) and recurrent aphthous stomatitis (RAS).
    Freysdottir J; Lau S; Fortune F
    Clin Exp Immunol; 1999 Dec; 118(3):451-7. PubMed ID: 10594567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotype markers and cytokine intracellular production by CD8+ gammadelta T lymphocytes do not support a regulatory T profile in Behçet's disease patients and healthy controls.
    Clemente A; Cambra A; Munoz-Saá I; Crespí C; Pallarés L; Juan A; Matamoros N; Julià MR
    Immunol Lett; 2010 Apr; 129(2):57-63. PubMed ID: 20167234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-DR and DQ antigens in Chinese patients with Behçet's disease.
    Sun A; Lin SC; Chu CT; Chiang CP
    J Oral Pathol Med; 1993 Feb; 22(2):60-3. PubMed ID: 8445544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased senescent CD8+ T cells in the peripheral blood mononuclear cells of Behçet's disease patients.
    Yang JY; Park MJ; Park S; Lee ES
    Arch Dermatol Res; 2018 Mar; 310(2):127-138. PubMed ID: 29255925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligoclonal T cell expansions in patients with Behçet's disease.
    Direskeneli H; Eksioglu-Demiralp E; Kibaroglu A; Yavuz S; Ergun T; Akoglu T
    Clin Exp Immunol; 1999 Jul; 117(1):166-70. PubMed ID: 10403931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-A, B (Class I) and HLA-DR, DQ (Class II) antigens in Turkish patients with recurrent aphthous ulceration and Behçet's disease.
    Pekiner FN; Aytugar E; Demirel GY; Borahan MO
    Med Princ Pract; 2013; 22(5):464-8. PubMed ID: 23485763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D modulates peripheral immunity in patients with Behçet's disease.
    Hamzaoui K; Ben Dhifallah I; Karray E; Sassi FH; Hamzaoui A
    Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S50-7. PubMed ID: 20868571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synovial lymphoid neogenetic factors in Behçet's synovitis: do they play a role in self-limiting and subacute course of arthritis?
    Pay S; Musabak U; Simsek I; Erdem H; Pekel A; Sengul A; Dinc A
    Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S21-6. PubMed ID: 17949547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of HLA-DR, DQ and DP antigens and interleukin-2 receptor on synovial fluid T lymphocyte subsets in rheumatoid arthritis: evidence for "frustrated" activation.
    Pitzalis C; Kingsley G; Lanchbury JS; Murphy J; Panayi GS
    J Rheumatol; 1987 Aug; 14(4):662-6. PubMed ID: 3118018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
    Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
    J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristic patterns of HLA presentation and T cell differentiation in adult-onset Still's disease.
    Jung JY; Choi B; Sayeed HM; Suh CH; Kim YW; Kim HA; Sohn S
    Int J Immunopathol Pharmacol; 2018; 32():2058738418791284. PubMed ID: 30052100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased frequencies of interleukin-2- and interferon-gamma-producing T cells in patients with active Behçet's disease.
    Sugi-Ikai N; Nakazawa M; Nakamura S; Ohno S; Minami M
    Invest Ophthalmol Vis Sci; 1998 May; 39(6):996-1004. PubMed ID: 9579479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of CD94/NKG2A, CD94/NKG2C, and its ligand HLA-E polymorphisms with Behcet's disease.
    Seo J; Park JS; Nam JH; Bang D; Sohn S; Lee ES; Park KS
    Tissue Antigens; 2007 Oct; 70(4):307-13. PubMed ID: 17767552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased CD4+CD16+ and CD4+CD56+ T cell subsets in Behçet's disease.
    Eksioglu-Demiralp E; Direskeneli H; Ergun T; Fresko I; Akoglu T
    Rheumatol Int; 1999; 19(1-2):23-6. PubMed ID: 10651077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell epitope expression of mycobacterial and homologous human 65-kilodalton heat shock protein peptides in short term cell lines from patients with Behçet's disease.
    Pervin K; Childerstone A; Shinnick T; Mizushima Y; van der Zee R; Hasan A; Vaughan R; Lehner T
    J Immunol; 1993 Aug; 151(4):2273-82. PubMed ID: 7688396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular cytokine patterns in Behçet's disease in comparison to ankylosing spondylitis--influence of treatment with interferon-alpha2a.
    Amberger M; Groll S; Günaydin I; Deuter C; Vonthein R; Kötter I
    Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S52-7. PubMed ID: 17949552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.